Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar TMFCane (56.30) Submitted: 6/21/2012 11:25:48 AM : Outperform Start Price: $11.12 ARNA Score: -53.33

Taking a gamble that Lorcaserin makes it. If not, lose. That's how the pharma game is.

Featured Broker Partners


Advertisement